Development of treatments for Down syndrome
Lancet Neurol
.
2022 Jan;21(1):22-23.
doi: 10.1016/S1474-4422(21)00411-7.
Author
Michael S Rafii
1
Affiliation
1
Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA 92121, USA. Electronic address: mrafii@usc.edu.
PMID:
34942129
PMCID:
PMC11108095
DOI:
10.1016/S1474-4422(21)00411-7
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Down Syndrome* / therapy
Humans
Grants and funding
R61 AG066543/AG/NIA NIH HHS/United States